Sphinx (Netherlands)

Institution (Company)

ROR

Also Known As

Sphinx (Netherlands)

Publications

3.8K

Citations

Authors

Concepts

About

Sphinx (Netherlands) is a company institution in Maastricht, Netherlands known for medicine, pathology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	12	472
2	Engineering	3	3	169
3	Language Studies	1	1	140
4	Public Health	1	3	117
5	Social Sciences	1	1	20

Sphinx (Netherlands)

Publications

3.8K

Citations

Page 1

	Year	Citations
Bridging the Quantitative-Qualitative Divide Richard Bolden, Jean Moscarola Social Science Computer Review EngineeringSemantic WebCorpus LinguisticsJournalismQuantitative Variables	2000	140
Genistein in Sanfilippo disease: A randomized controlled crossover trial Jessica de Ruijter, M. J. Valstar, Magdalena Narajczyk, Annals of Neurology	2011	111
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care Marc J. Sirks, Elon H. C. van Dijk, Noa Rosenberg, Acta Ophthalmologica	2022	88
Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosis Linda van der Tol, Einar Svarstad, Alberto Ortíz, Molecular Genetics and Metabolism Glomerular DiseaseGlomerulonephritisHemodialysisUrologyRenal Disease	2014	63
Prevalence of symptoms in female Fabry disease patients: a case‐control survey Machtelt G. Bouwman, Saskia M. Rombach, Erica Schenk, Journal of Inherited Metabolic Disease	2012	43
Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross‐sectional national survey Marion M. Brands, Deniz Güngör, Johanna M. P. den van Hout, Journal of Inherited Metabolic Disease	2014	43
High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): A national, observational, cross-sectional study Jessica de Ruijter, Mario Maas, Anneloes Janssen, Molecular Genetics and Metabolism Clinical EpidemiologyHigh PrevalenceSanfilippo DiseasePublic HealthOrthopaedic Surgery	2013	39
Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening Minke H. de Ru, Machtelt G. Bouwman, Frits A. Wijburg, Molecular Genetics and Metabolism Early DiagnosisMedical EthicsNewborn ScreeningNeonatologyMucopolysaccharidosis Type	2012	36
Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression Sanne J. van der Veen, Simon Körver, Alexander Hirsch, Molecular Genetics and Metabolism	2021	34
Thermodiffusion of repulsive charged nanoparticles – the interplay between single-particle and thermoelectric contributions Rafael Cabreira Gomes, A. Ferreira da Silva, Mansour Kouyaté, Physical Chemistry Chemical Physics	2018	32

Page 1